claim
Therapeutic immunosuppressive strategies to reduce IFN or IFN-related pathway signaling are associated with an increased risk of malignancy and infection.
Authors
Sources
- Editorial: Inflammation and chronic disease - Frontiers www.frontiersin.org via serper